» Articles » PMID: 33655498

Astrocytes Are HIV Reservoirs in the Brain: A Cell Type with Poor HIV Infectivity and Replication but Efficient Cell-to-cell Viral Transfer

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2021 Mar 3
PMID 33655498
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The major barrier to eradicating Human immunodeficiency virus-1 (HIV) infection is the generation of tissue-associated quiescent long-lasting viral reservoirs refractory to therapy. Upon interruption of anti-retroviral therapy (ART), HIV replication can be reactivated. Within the brain, microglia/macrophages and a small population of astrocytes are infected with HIV. However, the role of astrocytes as a potential viral reservoir is becoming more recognized because of the improved detection and quantification of HIV viral reservoirs. In this report, we examined the infectivity of human primary astrocytes in vivo and in vitro, and their capacity to maintain HIV infection, become latently infected, be reactivated, and transfer new HIV virions into neighboring cells. Analysis of human brain tissue sections obtained from HIV-infected individuals under effective and prolonged ART indicates that a small population of astrocytes has integrated HIV-DNA. In vitro experiments using HIV-infected human primary astrocyte cultures confirmed a low percentage of astrocytes had integrated HIV-DNA, with poor to undetectable replication. Even in the absence of ART, long-term culture results in latency that could be transiently reactivated with histone deacetylase inhibitor, tumor necrosis factor-alpha (TNF-α), or methamphetamine. Reactivation resulted in poor viral production but efficient cell-to-cell viral transfer into cells that support high viral replication. Together, our data provide a new understanding of astrocytes' role as viral reservoirs within the central nervous system (CNS).

Citing Articles

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model.

Martinez-Meza S, Premeaux T, Cirigliano S, Friday C, Michael S, Mediouni S J Neuroinflammation. 2025; 22(1):66.

PMID: 40045391 PMC: 11881274. DOI: 10.1186/s12974-025-03375-w.


Imaging Flow Cytometry in HIV Infection Research: Advantages and Opportunities.

Elfimov K, Baboshko D, Gashnikova N Methods Protoc. 2025; 8(1).

PMID: 39997638 PMC: 11858172. DOI: 10.3390/mps8010014.


Multi-omic Characterization of HIV Effects at Single Cell Level across Human Brain Regions.

Yang J, Agrawal K, Stanley 3rd J, Stanley J, Li R, Jacobs N bioRxiv. 2025; .

PMID: 39975288 PMC: 11839123. DOI: 10.1101/2025.02.05.636707.


The challenges to detect, quantify, and characterize viral reservoirs in the current antiretroviral era.

Gutierrez H, Eugenin E NeuroImmune Pharm Ther. 2025; 3(3-4):211-219.

PMID: 39845128 PMC: 11751450. DOI: 10.1515/nipt-2024-0017.


Transactivation of Human Endogenous Retroviruses by Viruses.

Evans E, Saraph A, Tokuyama M Viruses. 2024; 16(11).

PMID: 39599764 PMC: 11599155. DOI: 10.3390/v16111649.


References
1.
Rothenberger M, Keele B, Wietgrefe S, Fletcher C, Beilman G, Chipman J . Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc Natl Acad Sci U S A. 2015; 112(10):E1126-34. PMC: 4364237. DOI: 10.1073/pnas.1414926112. View

2.
Marban C, Forouzanfar F, Ait-Ammar A, Fahmi F, El Mekdad H, Daouad F . Targeting the Brain Reservoirs: Toward an HIV Cure. Front Immunol. 2016; 7:397. PMC: 5044677. DOI: 10.3389/fimmu.2016.00397. View

3.
Velasquez S, Prevedel L, Valdebenito S, Gorska A, Golovko M, Khan N . Circulating levels of ATP is a biomarker of HIV cognitive impairment. EBioMedicine. 2019; 51:102503. PMC: 7000317. DOI: 10.1016/j.ebiom.2019.10.029. View

4.
Hughes K, Akturk G, Gnjatic S, Chen B, Klotman M, Blasi M . Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages. AIDS. 2020; 34(11):1581-1591. PMC: 7579771. DOI: 10.1097/QAD.0000000000002589. View

5.
Hazleton J, Berman J, Eugenin E . Purinergic receptors are required for HIV-1 infection of primary human macrophages. J Immunol. 2012; 188(9):4488-95. PMC: 3508684. DOI: 10.4049/jimmunol.1102482. View